How will the healthcare industry be different in a post-pandemic world?

by John R. Fischer, Senior Reporter | April 20, 2020

3D Printing Artificial Intelligence Business Affairs Health IT

Medical imaging providers should expect changes in their supply chains, due to the impact of the China lockdown and a decrease in imaging unit shipments in H1. More opportunities for assembly and parts, however, are expected to be found in markets in Latin America and Eastern Europe.

Patient engagement and point-of-care testing
COVID-19 isolation has increased demand for engagement at home, which is partially responsible for the rise in telemedicine. Chronic disease cases and backlogs in elective procedures are anticipated to push OEMs to collaborate with providers on new patient management models.

Reveal 35C: spectral bedside imaging, no extra dose, now available in the EU

KA Imaging’s Reveal 35C detector, currently available as an upgrade solution in the US and selected geographies, can now be sold in the European Union. The detector recently obtained the CE Mark. Contact us at sales@kaimaging.com to book a free demo.

Additional changes include the use of testing services at retail clinics and the adoption of home-based testing modalities.

"While we recognize the tragedy that COVID-19 has caused the world, we also realize that it has opened many opportunities for companies to rejuvenate in this 'new normal' ecosystem,” said Reenita Das, Transformational Health senior vice president and partner, Frost & Sullivan, in a statement.

Frost & Sullivan did not respond for comment.

Back to HCB News



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!